Pharmacological management of a teen with significant alcohol use and depression.
Kratochvil
Christopher J
CJ
Dr. Kratochvil is with the Department of Psychiatry, University of Nebraska Medical Center, Omaha; Dr. Kazura is with the Bradley Hasbro Children's Research Center, Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI; Dr. Deas is with the Medical University of South Carolina, Charleston; Dr. Martin is with the Department of Psychiatry and Ms. Dosh is with the College of Medicine, University of Kentucky, Lexington; and Dr. Wilens is with the Pediatric Psychopharmacology Unit, Massachusetts General Hospital and Harvard Medical School, Boston.. Electronic address: ckratoch@unmc.edu.
Kazura
Alessandra
A
Dr. Kratochvil is with the Department of Psychiatry, University of Nebraska Medical Center, Omaha; Dr. Kazura is with the Bradley Hasbro Children's Research Center, Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI; Dr. Deas is with the Medical University of South Carolina, Charleston; Dr. Martin is with the Department of Psychiatry and Ms. Dosh is with the College of Medicine, University of Kentucky, Lexington; and Dr. Wilens is with the Pediatric Psychopharmacology Unit, Massachusetts General Hospital and Harvard Medical School, Boston.
Deas
Deborah
D
Dr. Kratochvil is with the Department of Psychiatry, University of Nebraska Medical Center, Omaha; Dr. Kazura is with the Bradley Hasbro Children's Research Center, Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI; Dr. Deas is with the Medical University of South Carolina, Charleston; Dr. Martin is with the Department of Psychiatry and Ms. Dosh is with the College of Medicine, University of Kentucky, Lexington; and Dr. Wilens is with the Pediatric Psychopharmacology Unit, Massachusetts General Hospital and Harvard Medical School, Boston.
Martin
Catherine A
CA
Dr. Kratochvil is with the Department of Psychiatry, University of Nebraska Medical Center, Omaha; Dr. Kazura is with the Bradley Hasbro Children's Research Center, Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI; Dr. Deas is with the Medical University of South Carolina, Charleston; Dr. Martin is with the Department of Psychiatry and Ms. Dosh is with the College of Medicine, University of Kentucky, Lexington; and Dr. Wilens is with the Pediatric Psychopharmacology Unit, Massachusetts General Hospital and Harvard Medical School, Boston.
Dosh
Tyanne
T
Dr. Kratochvil is with the Department of Psychiatry, University of Nebraska Medical Center, Omaha; Dr. Kazura is with the Bradley Hasbro Children's Research Center, Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI; Dr. Deas is with the Medical University of South Carolina, Charleston; Dr. Martin is with the Department of Psychiatry and Ms. Dosh is with the College of Medicine, University of Kentucky, Lexington; and Dr. Wilens is with the Pediatric Psychopharmacology Unit, Massachusetts General Hospital and Harvard Medical School, Boston.
Wilens
Timothy E
TE
Dr. Kratochvil is with the Department of Psychiatry, University of Nebraska Medical Center, Omaha; Dr. Kazura is with the Bradley Hasbro Children's Research Center, Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI; Dr. Deas is with the Medical University of South Carolina, Charleston; Dr. Martin is with the Department of Psychiatry and Ms. Dosh is with the College of Medicine, University of Kentucky, Lexington; and Dr. Wilens is with the Pediatric Psychopharmacology Unit, Massachusetts General Hospital and Harvard Medical School, Boston.
D000293:Adolescent; D000437:Alcoholism / Q000150:complications* / Q000188:drug therapy*; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003863:Depression / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D009271:Naltrexone / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D020280:Sertraline / Q000627:therapeutic use*
D000928:Antidepressive Agents; D009292:Narcotic Antagonists; D009271:Naltrexone; D020280:Sertraline